Use of isavuconazole in a patient with voriconazole‐induced QTc prolongation
Sign Up to like & getrecommendations! Published in 2017 at "Transplant Infectious Disease"
DOI: 10.1111/tid.12712
Abstract: A 22‐year‐old woman with cystic fibrosis developed QTc interval prolongation following lung transplantation in the setting of voriconazole therapy. After the discontinuation of voriconazole and initiation of isavuconazole, her QTc interval normalized. This case highlights… read more here.
Keywords: use isavuconazole; isavuconazole patient; voriconazole induced; qtc interval ... See more keywords